SuperworthRoivant Sciences market cap ROIV
Share price times shares outstanding: what the whole company sells for, since 2021.
- Today, Oct 23, 2026
- $26.4B
- Highest close in our data
- $29.5B
- Sep 2026
Roivant Sciences is worth $26.4B at the close on Oct 23, 2026, at $36.49 a share.
That is up 112% over the last year and up 1391% over five years.
Its highest close in our data was $29.5B in Sep 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $26.4B | $15B | $29.5B | +70% |
| 2025 | $15.5B | $6.8B | $15.6B | +80% |
| 2024 | $8.6B | $7.7B | $9.5B | −5% |
| 2023 | $9B | $5.2B | $9.7B | +56% |
| 2022 | $5.8B | $2.1B | $5.9B | −16% |
| 2021 | $6.9B | $1.3B | $8.2B | n/a |
Against its peers
Companies in Biotechnology nearest Roivant Sciences' size, closest first, today.
| Company | Market cap |
|---|---|
| ROIVRoivant Sciences | $26.4B |
| UTHRUnited Therapeutics | $25.2B |
| INCYIncyte | $23.5B |
| ALNYAlnylam Pharmaceuticals | $30B |
| ONCBeOne Medicines | $42.9B |
| EXELExelixis | $16B |
| NBIXNeurocrine Biosciences | $14.5B |
| HALOHalozyme Therapeutics | $14.3B |
| TECHBIO-TECHNE | $11.4B |
| RGENRepligen | $10B |
| KRYSKrystal Biotech | $9.2B |
| Peer median | $15.2B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Roivant Sciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.